CRISPR Breakthrough Blocks SARS-CoV-2 Virus Replication in Early Lab Tests

Virologists Demonstrate Successful Treatment for SARS-CoV-2, the Virus That Causes COVID-19

This Gene Editing Startup Raised $315 Million For A Next Generation Crispr Tool To Cure Rare Diseases

International Study Shows Laboratory Developed Protein Spikes Consistent With COVID-19 Virus